Cargando…
Inhibition of CDKL3 downregulates STAT1 thus suppressing prostate cancer development
Prostate cancer poses a great threat to men’s health worldwide, yet its treatment is still limited by the unclear understanding of its molecular mechanisms. CDKL3 is a molecule with a recently discovered regulatory role in human tumors, and its relationship with prostate cancer is unknown. The outco...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006411/ https://www.ncbi.nlm.nih.gov/pubmed/36899018 http://dx.doi.org/10.1038/s41419-023-05694-3 |